Skip to main content

Table 1 Study treatments

From: Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis

Anti-TNF drug

Posology according to SPC

Route

Full-dose group

Reduced-dose group

Adalimumab

40 mg every 2 weeks

SC

40 mg every 2 weeks

40 mg every 3 weeks

Etanercept

25–50 mg every 3–7 days

SC

25 mg every 3 days or

50 mg every 7 days

50 mg every 10 days

Golimumab

50 mg every month

SC

50 mg every 4 weeks

50 mg every 6 weeks

Infliximab

5 mg/Kg every 6–8 weeks

IV

5 mg/Kg every 6–8 weeks

3 mg/Kg every 8 weeks

  1. SPC Summary of Product Characteristics, SC subcutaneous, IV intravenous